FMP
Eucrates Biomedical Acquisition Corp.
EUCR
NASDAQ
Inactive Equity
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
10.04 USD
0 (0%)
About
ceo
Mr. Parag Phoolchand Saxena MBA, MS
sector
Financial Services
industry
Shell Companies
website
N/A
exchange
NASDAQ
Description
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
CIK
0001822929
ISIN
VGG3141W1068
CUSIP
G3141W106
Address
250 West 55th Street
Phone
212 710 5220
Country
US
Employee
N/A
IPO Date
Dec 28, 2020
Key Executives
